Tilray — Shares of the Canadian cannabis producer shot up more than 40 percent in the premarket after CEO Brendan Kennedy hinted to CNBC’s Jim Cramer that partnerships between pot companies and alcohol companies and pharmaceuticals could be coming. “If you’re an investor in a pharmaceutical company or you’re a pharmaceutical company, you have to hedge the offset from cannabis substitution,” he said. “I think all the alcohol companies need to enter this industry. It’s a great hedge for them.”

E-Trade — Jefferies upgraded the online broker’s stock to “buy” from “hold,” citing an attractive valuation as well as the company’s scale and revenue diversity at a time when competition in the space heats up. E-Trade’s potential as a buyout candidate also makes it attractive, Jefferies said.

Juniper Networks — Nomura Instinet upgraded Juniper shares to “buy” from “neutral,” and hiked its price target to $34 a share from $28. The analysts also raised their 2019 sales estimate to 5 percent and noted: “We expect Juniper to recover from its webscale routing annus horribilis, gain share in webscale switching, and continue its enterprise growth.”